FDA: Possible Fracture Risk with High Dose, Long-term Use of Proton Pump Inhibitors

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: FDA: Possible Fracture Risk with High Dose, Long-term Use of Proton Pump Inhibitors

FDA: Possible Fracture Risk with High Dose, Long-term Use of Proton Pump Inhibitors
Tue, 25 May 2010 14:53:00 -0500

The U.S. Food and Drug Administration today warned consumers and health care professionals about a possible increased risk of fractures of the hip, wrist, and spine with high doses or long-term use of a class of medications called proton pump inhibitors. The product labeling will be changed to describe this possible increased risk.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? support@xxxxxxxxxxxxxxx
• Other inquiries? webmail@xxxxxxxxxx

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · 10903 New Hampshire Ave MD 20993 · 800-439-1420